Evidence map›Paper›PMID 34034649›Full record

ArticleBMC infectious diseases2021

Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran.

Mohammad-Reza Sohrabi, Rozhin Amin, Ali Maher, Ayad Bahadorimonfared, Shahriar Janbazi, Khatereh Hannani, Ali-Asghar Kolahi, Ali-Reza Zali

Abstract readMulticenter Study
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad-Reza SohrabiCommunity Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rozhin AminCommunity Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali MaherSchool of Management and Medical Education, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ayad BahadorimonfaredCommunity Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahriar JanbaziSocial Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Khatereh HannaniStatistics & Information Technology Management, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali-Asghar KolahiCommunity Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali-Reza ZaliFunctional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. drazali@sbmu.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDefining socio-demographic factors, clinical presentations and underlying diseases associated with COVID-19 severity could be helpful in its management. This study aimed to further clarify the determinants and clinical risk factors of the disease severity in patients infected with COVID-19.

methodsA multi-centre descriptive study on all patients who have been diagnosed with COVID-19 in the province of Tehran from March 2020 up to Dec 2020 was conducted. Data on socio-demographic characteristics, clinical presentations, comorbidities, and the health outcomes of 205,654 patients were examined. Characteristics of the study population were described. To assess the association of study variables with the disease severity, the Chi-Squared test and Multiple Logistic Regression model were applied.

resultsThe mean age of the study population was 52.8 years and 93,612 (45.5%) were women. About half of the patients have presented with low levels of blood oxygen saturation. The ICU admission rate was 17.8% and the overall mortality rate was 10.0%. Older age, male sex, comorbidities including hypertension, cancer, chronic respiratory diseases other than asthma, chronic liver diseases, chronic kidney diseases, chronic neurological disorders, and HIV/AIDS infection were risk markers of poor health outcome. Clinical presentations related with worse prognosis included fever, difficulty breathing, impaired consciousness, and cutaneous manifestations.

conclusionThese results might alert physicians to pay attention to determinants and risk factors associated with poor prognosis in patients with COVID-19. In addition, our findings aid decision makers to emphasise on vulnerable groups in the public health strategies that aim at preventing the spread of the disease and its mortalities.

Indexed as

SARS-CoV-2AdolescentAdultAgedAged, 80 and overChildChild, PreschoolChi-Square DistributionChronic DiseaseComorbidityCOVID-19Cross-Sectional StudiesFemaleHIV InfectionsHumansHypertensionBlood oxygen saturationCOVID-19DeterminantsHealth outcomeIranSARS-CoV-2Severity

Identifiers

PMID34034649
PMCPMC8146170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.